人类骨肌肉病变 肌肉素突变 破坏肌肉素头部绑定
Glenn Carrington1,2, Abbi Hau3,4, Sarah Kosta5
1The Astbury Centre for Structural and Molecular Biology and.
JCI insight
|October 3, 2023
概括
在MYH7和MYH2基因中发生的突变会破坏肌结构,增加肌肉纤维中的ATP需求,而不会影响收缩性. 这一发现提供了关于肌肉细胞异位症和潜在的治疗策略的见解.
科学领域:
- 肌肉生理学 肌肉生理学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肌酸重链 (MYH7,MYH2) 对于骨肌肉收缩至关重要.
- 骨髓炎病因于MYH基因的突变引起,但潜在的机制尚不清楚.
- 轻度美罗米素 (LMM) 区域在肌肉素结构和功能中的作用至关重要.
研究的目的:
- 研究MYH7和MYH2突变在LMM区域的结构和功能后果.
- 为了阐明这些突变对肌肉蛋白的ATP消耗和脑部状态的影响,在体内.
- 为了确定LMM突变是否影响肌纤维收缩性.
主要方法:
- 在模拟和分析表达/净化LMM突变蛋白.
- 使用光ATP模拟追逐和X射线衍射进行肌肉活检分析.
- 肌纤维力学实验,以评估收缩功能.
主要成果:
- 在实验室中,MYH7和MYH2的LMM突变破坏了髓线圈结构和丝包装.
- 在体内研究显示,基底肌肉酶ATP消耗增加,超放松状态下降.
- 尽管发生了结构变化,肌纤维收缩性仍然不受影响.
结论:
- 通过损害"关闭头"的形成,增加ATP需求,LMM突变诱导了一种致病性状态.
- 主要影响是肌肉蛋白的能量消耗,而不是收缩力产生.
- 这些发现为开发针对肌肉细胞异位症的向治疗提供了基础.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Overview of Myosin Structure and Function
4.4K
Myosins are a family of molecular motor proteins, first identified in the skeletal muscles, where they are responsible for muscle contraction. Along with their role in muscle contraction, these proteins also play a role in the intracellular transport of molecules and vesicles. There are twenty-four classes of myosins based on their domain sequence and organization. Of the twenty-four, six classes (Myosin I, Myosin II, Myosin V, Myosin VI, Myosin VII, and Myosin X) have been well...
4.4K
Disorders of the Skeletal Muscle
984
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
984
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


